PharmaBoardroom

Hatice Öncel – CEO, Ilko Pharmaceuticals

Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel explains the company’s investment in…

US Generics & Biosimilars: Five Takeaways from Access! 2021

Dan Leonard of the Association for Accessible Medicines (AAM) highlights five key takeaways from the organisation’s remote but dynamic annual…

Philipp Haas – Chairman of BOD & CEO, DEVA

As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country. Chairman of the Board and CEO Philipp…

APAC: Generic Penetration by Country

Generics penetration in the Asia-Pacific region by country for 2018. A full 90.3 percent of all medicines dispensed in India were generics compared to…

Russia Pharma News: Biocad Ramps up Sputnik V Manufacturing;…

The latest Russia Pharma News, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing, Geropharm’s deal to produce insulin in…

Dan Leonard – President & CEO, Association for…

Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM) since August 2020, outlines his key agenda priorities as head of the…

Marc-Olivier Geinoz – CEO, Dipharma SA

Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic diseases. Founder & CEO…

Securing the Conditions to Secure Our Meds

The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar medicines have on US healthcare today and introduces the ‘Secure…

Russia: $7.4 bln for Healthcare Modernisation; Generics Push;…

The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025, limits on pharma companies’…

Top 10 Global Generics & Biosimilars Companies

The top ten global generics and biosimilars companies according to a recent Informa Pharma Intelligence ranking for 2019. Sandoz leads the way in…

Viatris: Cost-Cutting Needed at New Generics Behemoth

In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and Pfizer's Upjohn generics unit finally…

Growth, COVID-19 Response & Essential Medicines Industry…

Graeme Duncan, CEO of ADVANZ PHARMA, highlights how the specialty generics firm has revitalized its operations since 2018 both culturally and…

Tagged with Generics